167 related articles for article (PubMed ID: 24315002)
1. Kidney transplantation in hereditary coproporphyria using tacrolimus and mycophenolate mofetil: a case report.
Telkes G; Pusztai A; Földes K; Langer RM
Transplant Proc; 2013; 45(10):3703-4. PubMed ID: 24315002
[TBL] [Abstract][Full Text] [Related]
2. [Immunosuppressive drug monitoring of cyclosporine, tacrolimus, and mycophenolate mofetil in renal transplantation].
Uchida K
Nihon Jinzo Gakkai Shi; 2005; 47(4):423-9. PubMed ID: 15971884
[No Abstract] [Full Text] [Related]
3. Population Pharmacokinetic Analysis of Immediate-Release Oral Tacrolimus Co-administered with Mycophenolate Mofetil in Corticosteroid-Free Adult Kidney Transplant Recipients.
Rong Y; Mayo P; Ensom MHH; Kiang TKL
Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):409-422. PubMed ID: 30377942
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplantation with tacrolimus and steroid avoidance: four-year analysis.
Ciancio G; Gaynor JJ; Zarak A; Sageshima J; Guerra G; Roth D; Brown R; Kupin W; Chen L; Tueros L; Hanson L; Ruiz P; Burke GW
Transplantation; 2011 Jun; 91(11):1198-205. PubMed ID: 21107305
[TBL] [Abstract][Full Text] [Related]
5. Long-term dosing patterns of enteric-coated mycophenolate sodium or mycophenolate mofetil with tacrolimus after renal transplantation.
Langone A; Shihab F; Pankewycz O; Doria C; Wiland A; McCague K; Chan L
Clin Transplant; 2014 Sep; 28(9):961-7. PubMed ID: 24893821
[TBL] [Abstract][Full Text] [Related]
6. Pre-transplant pharmacokinetic profiling and tacrolimus requirements post-transplant.
Campbell S; Hawley C; Irish A; Hutchison B; Walker R; Butcher BE; Ferrari P
Nephrology (Carlton); 2010 Oct; 15(7):714-9. PubMed ID: 21040167
[TBL] [Abstract][Full Text] [Related]
7. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
8. Elevated tacrolimus trough levels in association with mycophenolate mofetil-induced diarrhea: a case report.
Frühwirth M; Fischer H; Simma B; Ellemunter H
Pediatr Transplant; 2001 Apr; 5(2):132-4. PubMed ID: 11328552
[TBL] [Abstract][Full Text] [Related]
9. Quadruple immunosuppression with basiliximab, tacrolimus, mycophenolate mofetil and prednisone is safe and effective for renal transplantation.
Miura M; Harada H; Fukuzawa N; Iwami D; Taniguchi A; Seki T; Togashi M; Ogawa Y; Satoh H; Hirano T
Clin Transplant; 2005; 19 Suppl 14():54-8. PubMed ID: 15955170
[TBL] [Abstract][Full Text] [Related]
10. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.
Nashan B; Saliba F; Durand F; Barcéna R; Herrero JI; Mentha G; Neuhaus P; Bowles M; Patch D; Bernardos A; Klempnauer J; Bouw R; Ives J; Mamelok R; McKay D; Truman M; Marotta P
Liver Transpl; 2009 Feb; 15(2):136-47. PubMed ID: 19177449
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisone in Chinese renal transplant recipients.
Chen YH; Zheng KL; Chen LZ; Dai YP; Fei JG; Qiu J; Li J
Transplant Proc; 2005 Dec; 37(10):4246-50. PubMed ID: 16387090
[TBL] [Abstract][Full Text] [Related]
13. Effect of mild diarrhea on tacrolimus exposure.
van Boekel GA; Aarnoutse RE; van der Heijden JJ; Hoogtanders KE; Hilbrands LB
Transplantation; 2012 Oct; 94(7):763-7. PubMed ID: 22955188
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetic analysis of mycophenolic acid coadministered with either tasocitinib (CP-690,550) or tacrolimus in adult renal allograft recipients.
Lamba M; Tafti B; Melcher M; Chan G; Krishnaswami S; Busque S
Ther Drug Monit; 2010 Dec; 32(6):778-81. PubMed ID: 20926996
[TBL] [Abstract][Full Text] [Related]
15. Relationship of tacrolimus exposure and mycophenolate mofetil dose with renal function after renal transplantation.
Ekberg H; van Gelder T; Kaplan B; Bernasconi C
Transplantation; 2011 Jul; 92(1):82-7. PubMed ID: 21562449
[TBL] [Abstract][Full Text] [Related]
16. Two case reports of successful withdrawal of mycofenolate mofetil after living donor lobar lung transplantation.
Miyazaki T; Tagawa T; Yamasaki N; Tsuchiya T; Matsumoto K; Nagayasu T
Transplant Proc; 2013; 45(1):356-9. PubMed ID: 23375323
[TBL] [Abstract][Full Text] [Related]
17. [Daclizumab in combination with mycophenolate mofetil and a late introduction of Tacrolimus at low doses, as a therapeutic approach in the elderly renal transplant donor-recipients pairs in kidney transplant].
Gentil MA; Osuna A; Capdevilla L; Cantarell C; Pereira P; Mazuecos A; González Molina M
Nefrologia; 2008; 28(3):287-92. PubMed ID: 18590495
[TBL] [Abstract][Full Text] [Related]
18. Results of one-year follow-up of steroid-free immunosuppression in pediatric renal transplant patients.
Silverstein DM; Aviles DH; LeBlanc PM; Jung FF; Vehaskari VM
Pediatr Transplant; 2005 Oct; 9(5):589-97. PubMed ID: 16176415
[TBL] [Abstract][Full Text] [Related]
19. Characterizing the role of enterohepatic recycling in the interactions between mycophenolate mofetil and calcineurin inhibitors in renal transplant patients by pharmacokinetic modelling.
Cremers S; Schoemaker R; Scholten E; den Hartigh J; König-Quartel J; van Kan E; Paul L; de Fijter J
Br J Clin Pharmacol; 2005 Sep; 60(3):249-56. PubMed ID: 16120063
[TBL] [Abstract][Full Text] [Related]
20. Late evolution of kidney transplants in elderly donors and recipients receiving initial immunosuppressant treatment with daclizumab, mycophenolate mofetil, and delayed introduction of tacrolimus.
González-Roncero FM; Gentil-Govantes MÁ; González-Molina M; Rivero M; Cantarell C; Alarcón A; Franco A; Sánchez-Plumed J; Lampreabe I; Lauzurica R; González E; Romero R; Ruiz-San Millán JC; Osuna A
Nefrologia; 2012 Jul; 32(4):446-54. PubMed ID: 22806279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
